Point-of-Care Diagnostics Market Size And Forecast Report 2024-2032

Point of Care Diagnostic Market Size

The Global Point-of-Care Diagnostics Market is forecasted to be valued at around US$82.28 billion by 2030, up from US$46.18 billion in 2023, with a CAGR of 8.60% from 2024 to 2030.

Point of Care Diagnostic Market Outlook

Point of Care (POC) diagnostics refers to medical testing conducted near or at the site of patient care, typically outside traditional laboratory settings. These tests provide rapid results, often within minutes, allowing for immediate clinical decisions and interventions. POC diagnostics encompass many tests, including blood glucose monitoring, pregnancy tests, blood gas analysis, and rapid tests for infectious diseases. The critical advantage of POC testing is its ability to deliver timely and actionable information, reducing the turnaround time for diagnosis and treatment initiation.

Request a free sample copy of the report: https://www.renub.com/point-of-care-diagnostic-market-p.php

The applications of POC diagnostics are diverse and increasingly important in modern healthcare. In emergency settings, they enable quick assessments of critical parameters like cardiac markers or blood coagulation status. In primary care, POC tests facilitate on-the-spot screening and monitoring of chronic conditions. During pandemics, such as the recent COVID-19 outbreak, POC tests have proven invaluable for rapid detection and containment efforts. Additionally, these tests are particularly beneficial in resource-limited settings, where access to centralized laboratory facilities may be challenging, thus improving healthcare accessibility and outcomes in underserved areas.

Growth Drivers of the Point of Care Diagnostic Market

1. Technological Advancements:
   Rapid technological progress is a primary driver of the Point of Care (POC) Diagnostic market growth. Innovations in microfluidics, nanotechnology, and biosensors enable the development of more sophisticated, accurate, and user-friendly POC devices. These advancements are miniaturizing complex laboratory tests, making them portable and accessible at the point of care. Integration with smartphones and other smart devices further enhances POC diagnostics’ capabilities, allowing for data analysis, storage, and transmission. Improvements in molecular diagnostic techniques, such as CRISPR-based systems, are expanding the range of tests that can be performed rapidly and accurately outside traditional laboratory settings.
2. Increasing Prevalence of Chronic Diseases:
   The global rise in chronic diseases significantly drives the demand for POC diagnostics. Conditions such as diabetes, cardiovascular diseases, and respiratory disorders require frequent monitoring, making POC tests invaluable for ongoing management. These tests enable patients and healthcare providers to make timely decisions about treatment adjustments, reducing the need for hospital visits and improving overall health outcomes. The aging population in many countries further contributes to this trend.
3. Healthcare Decentralization and Patient Empowerment:
   The ongoing trend of healthcare decentralization and increased patient empowerment is a significant growth driver for the POC diagnostic market. There’s a growing emphasis on moving healthcare services closer to patients, whether in community clinics, pharmacies, or homes. Patients are increasingly managing their health, driving demand for user-friendly, at-home diagnostic solutions. The push for value-based healthcare models encourages using POC tests to improve efficiency and reduce healthcare costs.

China Point-of-Care Diagnostics Market

The China Point-of-Care (POC) Diagnostics market is experiencing rapid growth, driven by several factors unique to the country’s healthcare landscape. China’s large population and increasing focus on improving healthcare accessibility, particularly in rural areas, have created a strong demand for POC tests. The government’s initiatives to enhance primary care and promote early disease detection have further bolstered this market.

However, challenges remain, including regulatory hurdles and the need for standardization. Despite these, the China POC Diagnostics market is poised for continued expansion, with opportunities in areas like chronic disease management, infectious disease testing, and personalized medicine.

Key Players in the Point-Of-Care Diagnostics Market

The global point-of-care diagnostics market includes companies such as:

• Sysmex
• Abbott Laboratories (US)
• Becton Dickinson and Company (US)
• Danaher Corporation (US)
• Quidel Diagnostics (US)
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.

Point-Of-Care Diagnostics Company News

• October 2023: QIAGEN obtained CE certification for its IVD kit and automated testing platform, NeuMoDx, positively impacting the company’s revenue and market share.
• March 2023: F. Hoffmann-La Roche Ltd. teamed up with Eli Lilly to develop the Elecsys Amyloid Plasma Panel (EAPP), designed to simplify the patient journey from diagnosis to treatment management.

Related Reports:

• Europe In-Vitro Diagnostics Market
• Germany In-Vitro Diagnostics Market
• United States In-Vitro Diagnostics Market

Products – Global Point-of-Care Diagnostics Market Breakup:

1. Glucose Monitoring Kits
2. Infectious Diseases Kits
3. Pregnancy & Fertility Testing Kits
4. Hematology Testing Kits
5. Cardiometabolic Monitoring Kits
6. Urinalysis Testing Kits
7. Cholesterol Test Strips
8. Drug Abuse Testing Kits
9. Others

Technology – Global Point-of-Care Diagnostics Market Breakup:

1. Lateral Flow
2. Agitation
3. Flow Through
4. Solid Phase
5. Biosensor
6. Others

Point of Prescription – Global Point-of-Care Diagnostics Market Breakup:

1. Prescription-Based Devices
2. Over-the-Counter (OTC)-Based Devices

End-User – Global Point-of-Care Diagnostics Market Breakup:

1. Professional Diagnostic Centers
2. Research Laboratories
3. Home Care
4. Others

Country – Global Point-of-Care Diagnostics Market Breakup of 25 Countries:

1. North America
   • United States
   • Canada
2. Europe
   • France
   • Germany
   • Italy
   • Spain
   • United Kingdom
   • Belgium
   • Netherlands
   • Turkey
3. Asia Pacific
   • China
   • Japan
   • India
   • South Korea
   • Thailand
   • Malaysia
   • Indonesia
   • Australia
   • New Zealand
4. Latin America
   • Brazil
   • Mexico
   • Argentina
5. Middle East & Africa
   • Saudi Arabia
   • UAE
   • South Africa

All Key Players Covered From 3 Viewpoints:

• Overview
• Recent Development
• Revenue Analysis

Company Analysis:

1. Sysmex
2. Abbott Laboratories (US)
3. Becton Dickinson and Company (US)
4. Danaher Corporation (US)
5. Quidel Diagnostics (US)
6. F. Hoffmann-La Roche Ltd
7. Thermo Fisher Scientific Inc.
8. Bio-Rad Laboratories Inc.

About the Company

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions on strategy, organization, operations, technology, mergers & acquisitions, etc. We have published more than 9000 syndicated reports and worked on over 750 custom research projects. Currently, we supply data to EMIS, Bloomberg, Thomson Reuters, etc., and support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: Renub Research
Website: www.renub.com